Mark A. Wan
Director, AcelRx Pharmaceuticals (United States).
Companies
- AcelRx Pharmaceuticals (United States)Board member Feb 10, 2011 to now1
- Athlon Acquisition Corp.Chair Jan 12, 2021 to Jan 12, 20212
- EpocratesBoard member Feb 1, 2011 to Mar 13, 20133
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
AcelRx Pharmaceuticals (United States) TLPH13,959 shares4$14.9K at $1.07Jun 22, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 22, 2026Granted 5,100 shares of AcelRx Pharmaceuticals (United States)4
- Oct 23, 2025Granted 4,267 shares of AcelRx Pharmaceuticals (United States)5
- Jun 24, 2024Granted 2,174 shares of AcelRx Pharmaceuticals (United States)6
- Oct 10, 2023Granted 581 shares of AcelRx Pharmaceuticals (United States)7
- Jul 15, 2022Granted 15,500 shares of AcelRx Pharmaceuticals (United States)8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARAthlon Acquisition Corp., Chair
- 3SEC EDGAREpocrates, Board member
- 4
- 5SEC EDGARForm 4 filed Oct 24, 2025
- 6SEC EDGARForm 4 filed Jun 24, 2024
- 7SEC EDGARForm 4 filed Dec 13, 2023
- 8SEC EDGARForm 4 filed Jul 15, 2022